FDA drops Whoop warning letter over blood pressure feature
Whoop made changes to its blood pressure insights feature that satisfied the FDA’s requirements for wellness devices.
Florida launches probe into CVS for alleged anticompetitive pharmacy practices
The investigation by Florida’s attorney general comes as states look to check pharmacy benefit managers for allegedly driving up drug costs.
US health spending spikes to $5.7T in 2025, though growth should moderate, CMS finds
Utilization — not cost growth — continues to accelerate spending, government actuaries said. Spiking prescription drug spending, including on GLP-1s, is especially acute.
Centene adds JPMorgan veteran to board
Incoming board member Lauren Tyler has more than 30 years of leadership experience in the finance world, which could help Centene navigate the challenging operating environment facing insurers.
Democrats push for more data on Medicare AI prior authorization pilot
The letter to the CMS from Democrats is the latest salvo from lawmakers concerned that WISeR is delaying care to Medicare beneficiaries.
HHS, responding to China’s rise, moves to fast-track early drug research
A series of newly planned reforms are designed to entice companies to start early trials in the U.S. rather than overseas.
Hackensack Meridian Health, Hunterdon Health explore merger in New Jersey
No one’s going out of business without a merger, as both HMH and Hunterdon are on stable financial footing. But a combination will give the systems added heft to tussle with competitors, according to executives.
The $50B rural health transformation fund is pushing many hospitals to shrink
To avoid losing funding, many states are pursuing proven cost-saving models, such as downsizing inpatient care, rather than novel, untested approaches, some experts say.
MultiCare CEO to retire at end of 2026
Florence Chang, a long-time executive of the Washington-based nonprofit, will replace current CEO William Robertson on Jan. 1.
HCA’s chief clinical officer to exit after 4 years
Dr. Michael Cuffe, who assumed the role in 2022, is leaving at the end of August.